Search

everythinglearnresearchcommunity

for

Search:↓

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Creating evidence-based guidelines for gender incongruence is difficult due to the personalized nature of transgender medicine.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.